Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

Contributed by: PR Newswire

Tags

Esco-Aster

More Like This

Business Wire logo

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

PR Newswire associated0

S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial

PR Newswire associated0

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

GlobeNewswire associated0

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma

PR Newswire associated0

Chromatin Bioscience Signs Collaboration Agreement with Astellas

ACCESSWIRE associated1

HanchorBio to Present at the ESMO Immuno-Oncology 2023 Annual Congress

PR Newswire associated0

Kimera® Labs Inc publishes novel brain targeting of exosomes in Nature Scientific Reports